← back to search

Hong Wang

Shandong University · CN
🔎 Find collaborators in Molecular Biology · Cancer Research →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Epigenetics and DNA Methylation, Cancer-related molecular mechanisms research, and CRISPR and Genetic Engineering.
h-index
48
citations
9,916
works
417
NIH funding
primary concept
Medicine
email

Recent publications

Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial
Nature Medicine 2025cited by 16position: middledoi
Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial
BMJ 2025cited by 4position: middledoi
Preliminary efficacy and safety of TQB2102 in patients with HER2 low-expressing recurrent/metastatic breast cancer: Results from a phase 1b study.
Journal of Clinical Oncology 2025cited by 2position: middledoi
Author Correction: Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial
Nature Medicine 2025cited by 1position: middledoi
Can large language models serve as digital assistants for medical undergraduates? - A bibliometric mapping and scoping analysis of the medical-education literature.
2025cited by 0position: contributordoi
ESG401, a trophoblast cell-surface antigen 2 (TROP2) antibody drug conjugate (ADC), for the treatment of first-line metastatic triple negative breast cancer (mTNBC).
Journal of Clinical Oncology 2024cited by 5position: middledoi
Immunotherapy: a promising approach for glioma treatment.
2023cited by 156position: contributordoi
Bibliometric study of immunotherapy for hepatocellular carcinoma.
2023cited by 20position: contributordoi
Immunotherapy in cervical cancer: From the view of scientometric analysis and clinical trials.
2023cited by 9position: contributordoi
The Role of Early Cerebral Edema and Hematoma assessment in Aneurysmal Subarachnoid Hemorrhage (a-SAH) in predicting Structural Brain Abnormalities in Cognitive Impairments
medRxiv 2023cited by 1position: lastdoi
Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-Adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C)
Clinical Gastroenterology and Hepatology 2022cited by 49position: middledoi
Clonal evolution characteristics and reduced dimension prognostic model for non-metastatic metachronous bilateral breast cancer.
2022cited by 1position: contributordoi
Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial
The Lancet Oncology 2021cited by 386position: middledoi
Δ40p53 isoform up-regulates netrin-1/UNC5B expression and potentiates netrin-1 pro-oncogenic activity
Proceedings of the National Academy of Sciences 2021cited by 19position: middledoi
Contribution of structural accessibility to the cooperative relationship of TF-lncRNA in myopia
Briefings in Bioinformatics 2021cited by 12position: firstdoi
SOD1 Promotes Cell Proliferation and Metastasis in Non-small Cell Lung Cancer via an miR-409-3p/SOD1/SETDB1 Epigenetic Regulatory Feedforward Loop
Frontiers in Cell and Developmental Biology 2020cited by 74position: middledoi
Insights into Biological Role of LncRNAs in Epithelial-Mesenchymal Transition
Cells 2019cited by 171position: middledoi
Histone methyltransferase NSD2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling
Acta Pharmacologica Sinica 2019cited by 60position: middledoi
Distinct features of H3K4me3 and H3K27me3 chromatin domains in pre-implantation embryos
Nature 2016cited by 771position: middledoi
Characterization of the Interactions between Calmodulin and Death Receptor 5 in Triple-negative and Estrogen Receptor-positive Breast Cancer Cells
Journal of Biological Chemistry 2016cited by 16position: middledoi
Inhibition of HIV-1 Viral Infection by an Engineered CRISPR Csy4 RNA Endoribonuclease
PLoS ONE 2015cited by 8position: middledoi
Dietary Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5- <i>b</i> ]Pyridine–Induced Prostate Carcinogenesis in CYP1A-Humanized Mice
Cancer Prevention Research 2012cited by 39position: middledoi
Identifying Grade/Stage-Related Active Modules in Human Co-regulatory Networks: A Case Study for Breast Cancer
OMICS A Journal of Integrative Biology 2012cited by 1position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yuanyuan Liu · Ningbo University2 papers (2025–2025)Dong Liu · Nantong University2 papers (2025–2025)Xing Li · Xuzhou Medical College2 papers (2025–2025)Bin Cao · Xi'an University of Science and Technology2 papers (2025–2025) · 2 papers (2025–2025)Yeming Wang · Academy of Medical Sciences2 papers (2025–2025)Yunsong Yu · Xi'an Jiaotong University2 papers (2025–2025)Yu Zhang · Shanxi Medical University2 papers (2025–2025) · 2 papers (2025–2025) · 2 papers (2025–2025)Jun Wei · Jiangsu University2 papers (2025–2025)Zhaolong Cao · Peking University2 papers (2025–2025)Anlin Ma · China Pharmaceutical University2 papers (2025–2025)Yan Ding · Huaihua University2 papers (2025–2025)Min Deng · Shenyang Pharmaceutical University2 papers (2025–2025)Zuke Xiao · Nanchang University2 papers (2025–2025) · 2 papers (2025–2025) · 2 papers (2025–2025) · 2 papers (2025–2025)Xiaoping Wu · Columbia University2 papers (2025–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Cancer Research →